Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Masato Ichihara"'
Publikováno v:
Advances in Horticultural Science, Vol 37, Iss 2 (2023)
The growth and yield of 13 red and green leaf lettuce (Lactuca sativa L.) cultivars were evaluated under two types of white LED irradiation. There was a difference in growth under the two types white LEDs, specifically in the fresh total weight, fres
Externí odkaz:
https://doaj.org/article/6e8d46696f03406da4d147fdbbbc4bc9
Publikováno v:
Materials Advances. 3:6451-6457
Catalase enwrapped covalently with human serum albumin incorporating protoporphyrin IX is a unique dual functional hemoprotein cluster (O2 generation and photosensitization) that can achieve enhanced photodynamic therapy.
Autor:
Tomioka Kenichi, Takeshi Shigenaga, Nami Hisamichi, Tomoko Nii, Ken-ichi Suzuki, Tomihisa Kawasaki, Isao Yanagisawa, Osamu Inagaki, Seiji Kaku, Yuzo Matsumoto, Kazuo Sato, Masato Ichihara, Yumiko Moritani, Seijiro Akamatsu
Publikováno v:
European Journal of Pharmacology. 439:43-52
The pharmacological properties of YM-57029 ({4-[4-(4-carbamimidoylphenyl)-3-oxopiperazin-1-yl]piperidino}acetic acid monohydrochloride trihydrate), a novel glycoprotein IIb/IIIa antagonist were examined in this study. YM-57029 inhibited fibrinogen bi
Autor:
Tomihisa Kawasaki, Kazuo Sato, Yumiko Moritani, Seiji Kaku, Hiroshi Arai, Ken-ichi Suzuki, Yuta Taniuchi, Yuzo Matsumoto, Isao Yanagisawa, Takeshi Shigenaga, Seijiro Akamatsu, Masato Ichihara, Tomoko Nii, Nami Hisamichi, Hiroshi Matsushima, Osamu Inagaki, Tomioka Kenichi
Publikováno v:
Drug Development Research. 55:149-161
We examined the biochemical properties of YM-57029 ({4-[4-(4-Carbamimidoylphenyl)-3-oxopiperazin-1-yl]piperidino}acetic acid monohydrochloride trihydrate) and the pharmacodynamics and pharmacokinetics of its prodrug, YM128 (Ethyl (Z)-(4-{4-[4-(N 2 -h
Autor:
Isao Yanagisawa, Masato Ichihara, Kumiko Shibasaki, Kazuo Murakami, Toichi Takenaka, Masayuki Shibasaki, Osamu Inagaki
Publikováno v:
European Journal of Pharmacology. 271:341-348
This report describes the pharmacological properties of a novel renin inhibitor (YM-26365: (3 R -3[3-[(1 S )-1-cyclohexylmethyl- 2-hydroxy-3-[(1-methyl-5-tetrazolyl)thio]propyl]ureido]-1-methyl-5-phenyl-2,3-dihydro-1 H -1,4-benzodiazepin-2-one) with
Autor:
Kazuyuki Hidaka, Masato Ichihara, Fumikazu Wanibuchi, Toshinari Tamura, Shinji Usuda, Masatomi Harada, Shin-ichi Tsukamoto
Publikováno v:
ChemInform. 24
A series of spirooxazolidine-2,4-dione derivatives related to the putative M1 agonist 2-ethyl-8-methyl-2,8-diazaspiro[4.5]decane-1,3-dione (RS86; 1) were synthesized. The compounds were evaluated as cholinergic agents in in vitro binding assays and i
Autor:
Fukushi Hirayama, Yuta Taniuchi, Kazuo Sato, Masato Ichihara, Hiroyuki Koshio, Yuzo Matsumoto, Nami Hisamichi, Tomihisa Kawasaki
Publikováno v:
European journal of pharmacology. 350(1)
The antithrombotic effects of a novel factor Xa inhibitor, YM-60828 ([N-[4-[(1-acetimidoyl-4-piperidyl)oxy]phenyl]-N-[(7-amidino-2-nap hthyl)methyl]sulfamoyl]acetic acid dihydrochloride), in three thrombosis models in guinea pigs were studied in comp
Autor:
Shinji Usuda, Toshinari Tamura, Shin-ichi Tsukamoto, Masato Ichihara, Fumikazu Wanibuchi, Kazuyuki Hidaka, Masatomi Harada
Publikováno v:
Journal of medicinal chemistry. 36(16)
A series of spirooxazolidine-2,4-dione derivatives related to the putative M1 agonist 2-ethyl-8-methyl-2,8-diazaspiro[4.5]decane-1,3-dione (RS86; 1) were synthesized. The compounds were evaluated as cholinergic agents in in vitro binding assays and i
Autor:
Yukiko Fukunaga, Masaharu Asano, Masato Ichihara, Kohji Nakano, Takashi Fujikura, Yukiyasu Murakami, Masayuki Shibasaki, Takashi Usui
Publikováno v:
American journal of hypertension. 4(12 Pt 1)
A novel renin inhibitor, YM-21095 [2RS), (3S)-3-[N alpha-[1,4-dioxo-4-morpholino-2-(1-naphthylmethyl)-buthyl]-L- histidil-amino]-4-cyclohexyl-1-[(1-methyl-5-tetrazolyl)thio]-2-but anol), has been synthesized in our laboratories. The aim of this study
Autor:
Hiroyuki Koshio, Fukushi Hirayama, Tomihisa Kawasaki, Masato Ichihara, Yuzo Matsumoto, Nami Hisamichi, Kazuo Sato
Publikováno v:
Japanese Journal of Pharmacology. 76:183